{"id":130401,"date":"2025-04-27T09:41:41","date_gmt":"2025-04-27T01:41:41","guid":{"rendered":"http:\/\/www.gocpmall.com\/?p=130401"},"modified":"2025-04-27T09:41:41","modified_gmt":"2025-04-27T01:41:41","slug":"%e5%8d%83%e4%ba%bf%e4%b8%ad%e6%88%90%e8%8d%af%e5%b8%82%e5%9c%ba%e7%ab%9e%e4%ba%89%e5%8a%a0%e5%89%a7%ef%bc%8c33%e6%ac%be%e4%b8%ad%e8%8d%af%e8%8e%b7%e6%89%b9%e4%b8%8a%e5%b8%82_%e8%b4%a2%e5%af%8c","status":"publish","type":"post","link":"https:\/\/www.gocpmall.com\/?p=130401","title":{"rendered":"\u5343\u4ebf\u4e2d\u6210\u836f\u5e02\u573a\u7ade\u4e89\u52a0\u5267\uff0c33\u6b3e\u4e2d\u836f\u83b7\u6279\u4e0a\u5e02_\u8d22\u5bcc\u53f7_\u4e1c\u65b9\u8d22\u5bcc\u7f51"},"content":{"rendered":"

\"news
在中药临床试验如火如荼开展之时，研发成果逐步兑现，申请上市、获批上市的中药药品数量不断提升。本文基于摩熵咨询最新发布的《数据透视：中药创新药、经典验方、改良型新药、同名同方的申报、获批、销售情况》报告中的精彩内容，对近五年申请上市、获批上市的中药进行了盘点，其中中药创新药达20款，经典名方11款，这些新药为千亿中成药市场注入了新的活力。（文末附完整表格） 一、近五年中药申请上市数据 2020-2024年总计有95项中药上市申请获CDE承办，药品数量达76款。其中2024年上市申请受理数量为41项，药品数量达30款。 分注册类型来看，近五年中药创新药是申请上市主力军，从2020年5款提升至2024年11款。古代经典名方近三年申请上市药品数量快速提升，上市进程加速。 数据来源：摩熵医药数据库（中国药品审评数据库） 单从2024年来看，申请上市数量最多的为3类古代经典名方，达17款；1类中药创新药紧随其后，达11款；同名同方药达2款。 数据来源：摩熵医药中国药品审评数据库 二、近五年中药获批上市数据 近五年获批上市的中药总计33款，包括中药创新药20款，古代经典名方11款，中药改良型新药1款，同名同方药1款。 中药创新药获批数量稳居首位，2021-2024年获批数量分别达6、6、5、3款，中药1类新药获批呈现出积极发展态势。 数据来源：摩熵医药中国药品审评数据库 2024年，我国古代经典名方审批迎来历史性突破，全年共有10款古代经典名方制剂获批上市，中药审评制度红利正在持续释放。 数据来源：摩熵医药中国药品审评数据库 从剂型来看，颗粒剂为中药品种主要剂型，占比约39%，其次为胶囊剂，占比约27%；从治疗领域来看，获批上市中药主要聚焦呼吸系统、神经系统、生殖泌尿系统等疾病领域，占比分别为21%、15%、15%。 截图来源：摩熵咨询《数据透视：中药创新药、经典验方、改良型新药、同名同方的申报、获批、销售情况》报告 三、33款获批中药汇总 近五年获批上市的中药创新药20款，古代经典名方11款盘点如下： 近五年获批上市的33款中药盘点如下： 本文作者可以追加内容哦 !
阅读更多（Read More）<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

在中药临床试&#39564 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-130401","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/posts\/130401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=130401"}],"version-history":[{"count":0,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=\/wp\/v2\/posts\/130401\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=130401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=130401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gocpmall.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=130401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}